Skip to main content
Natco Pharma Ltd. logo

Natco Pharma Ltd. — Investor Relations & Filings

Ticker · NATCOPHARM ISIN · INE987B01026 LEI · 33580086GIBRWXSNGG39 BSE.NS Manufacturing
Open in API
Filings indexed 1,708 across all filing types
Latest filing 2021-02-26 Regulatory Filings
Country IN India
Listing BSE.NS NATCOPHARM

About Natco Pharma Ltd.

https://www.natcopharma.co.in/

Natco Pharma Ltd. is a vertically integrated organization focused on the development, manufacturing, and marketing of complex generics and active pharmaceutical ingredients (APIs). The company specializes in niche therapeutic areas, maintaining a leadership position in oncology and a significant presence in specialty segments such as hepatology, cardiology, and diabetology. Natco is recognized for its expertise in high-barrier-to-entry products, including complex oral solids and injectables. Its business model emphasizes research and development to deliver affordable versions of life-saving medicines globally. With a robust portfolio of finished dosage formulations and a strong supply chain for APIs, the company serves diverse international markets, including North America, Europe, and emerging economies, through strategic partnerships and direct distribution channels.

Recent filings

Filing Released Lang Actions
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing the launch of a new pharmaceutical product, Brivaracetam tablets, by Natco Pharma Limited. It is addressed to stock exchanges and is intended for public information. The content focuses on product launch details, pricing, and market information, with no financial data, regulatory filings, or report attachments. The document length is short (2231 characters), and it is clearly a corporate announcement rather than a financial report or regulatory filing. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous corporate announcements that do not fit other specific categories.
2021-02-26 English
Copy of Newspaper Publication
Regulatory Filings Classification · 90% confidence The document text is extremely short (874 characters) and contains mostly placeholders for images with no substantive textual content or financial data. There are no references to any specific report, financial results, regulatory filings, or announcements. Given the lack of content and the presence of multiple omitted pictures, this document does not appear to be a full report or detailed filing. It is likely an announcement or a brief notice, but without clear indication of report publication or regulatory filing. Since it does not fit any specific category and lacks sufficient information, the best classification is Regulatory Filings (RNS) as a fallback category.
2021-02-15 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is titled as an "Investor Presentation for the Quarter ended December, 2020" and is addressed to stock exchanges. It contains detailed business overview, financial highlights, market strategy, product portfolio, and growth plans. The content is typical of a presentation aimed at investors, focusing on company strategy, market position, and financial performance highlights rather than a formal report or regulatory filing. There is no indication that this is a full annual or quarterly report, audit report, or earnings release. The document is not a brief announcement or a certification. Therefore, the document fits the category of an Investor Presentation (IP). The document length (15,000 characters) and detailed content support this classification with high confidence.
2021-02-15 English
copy of news paper publications
Regulatory Filings
2021-02-15 English
Investor presentation for the quarter and nine months ended December 31, 2020
Regulatory Filings
2021-02-15 English
Financial Result Updates
Regulatory Filings
2021-02-11 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.